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Insulin resistance is often associated with impeded
insulin signaling due either to decreased concentra-
tions or functional modifications of crucial signaling
molecules including insulin receptor substrates
(IRS) in the liver. Many actions of adiponectin, a
well-recognized antidiabetic adipokine, are currently
attributed to the activation of two critical molecules
downstream of AdipoR1 and R2: AMP-activated
kinase (AMPK) andperoxisomeproliferator-activated
receptor a (PPARa). However, the direct effects of
adiponectin on insulin signaling molecules remain
poorly understood. We show here that adiponectin
upregulates IRS-2 through activation of signal
transducer and activator of transcription-3 (STAT3).
Surprisingly, this activation is associated with IL-6
production frommacrophages induced by adiponec-
tin through NFkB activation independent of its
authentic receptors, AdipoR1 and AdipoR2. These
data have unraveled an insulin-sensitizing action initi-
ated by adiponectin leading to upregulation of
hepatic IRS-2 via an IL-6 dependent pathway through
a still unidentified adiponectin receptor.
INTRODUCTION
Insulin resistance is often caused by decreased levels of its
critical signaling molecules, functional modifications of these
proteins, or both (Hotamisligil et al., 1996; Taniguchi et al.,
2006). IRS-1 and IRS-2 are abundant in liver and are essential
regulators for glucose metabolism in physiological and patho-
logical circumstances (Dong et al., 2006; Kubota et al., 2008;
Sun et al., 1995; Tamemoto et al., 1994). IRS-2 expression is
preferentially decreased in the livers of obese model mice
(Shimomura et al., 2000), and disruption of hepatic IRS-2 leads
to insulin resistance (Kubota et al., 2000), suggesting thatChepatic IRS-2 as well as IRS-1 is critical for the pathogenesis
of systemic insulin resistance.
Adiponectin is an antidiabetic adipokine (Kadowaki et al.,
2006), which enhances insulin action by several mechanisms,
including suppression of gluconeogenesis and regulation of fatty
acid metabolism (Awazawa et al., 2009; Berg et al., 2001;
Yamauchi et al., 2001) as well as modulation of calcium signaling
in skeletal muscles (Iwabu et al., 2010). To date, most of these
actions have been attributed to the activation of two critical
molecules downstream of AdipoR1 and AdipoR2, AMPK, and
PPARa (Iwabu et al., 2010; Yamauchi et al., 2002; Yamauchi
et al., 2007). In obese model mice with insulin resistance, hypo-
adiponectinemia (Yamauchi et al., 2001) often coexists with
downregulation of hepatic insulin signaling; however, direct
effects of adiponectin on insulin signaling molecules remain
poorly investigated.
IL-6 is an inflammatory cytokine that has usually been related
to insulin resistance, although some reports have paradoxically
suggested that transient IL-6 upregulation contributes to
improved insulin sensitivity (for a comprehensive review, see
Pedersen and Febbraio, 2008). In contrast, adiponectin has
been reported to exert anti-inflammatory actions (Huang et al.,
2008), although it activatesNFkBand induces inflammatory cyto-
kines in some contexts (Haugen and Drevon, 2007). It is not
precisely understood how adiponectin is related to inflammatory
responses and cytokine production, including that of IL-6.
In this report, we show that adiponectin upregulates the IRS-2
protein thorough activation of STAT3 associated with IL-6
production from macrophages, independently of its authentic
receptors, AdipoR1 and AdipoR2. These data have unraveled
a novel adiponectin biology including the existence of an uniden-
tified receptor.
RESULTS
IRS-2 Expression Was Decreased in Livers
of Adiponectin-Deficient Mice, and Adiponectin
Administration Upregulated IRS-2 in Liver
To examine the direct effects of adiponectin on insulin signaling,
we first investigated the expression of insulin signalingell Metabolism 13, 401–412, April 6, 2011 ª2011 Elsevier Inc. 401
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Figure 1. IRS-2 Expression Was Decreased
in the Livers of Ad KO Mice
The representative blots of IRS-1 and IRS-2 in
the livers of Ad KO mice and their arbitrary quanti-
fications.
(A) Ad KO mice were sacrificed at the fasted state
and the liver lysates were immunoprecipitated and
immunoblotted with each antibody (n = 4, * p <
0.05).
(B) Ad KO mice were injected with insulin (Ins)
and the livers were removed at 5 min. The lysates
were immunoprecipitated with insulin receptor
(IR), IRS-1, and IRS-2 antibody, respectively, and
immunoblotted with 4G10 anti-phosphotyrosine
(pY) antibody (n = 4, * p < 0.05).
(C) Ad KOmicewere injectedwith adiponectin (Ad)
intraperitoneally and the livers were removed at
4 hr. The lysates were immunoprecipitated with
IRS-1 and IRS-2 antibody, respectively, and im-
munoblotted with pY, IRS-1 and IRS-2 antibody.
Error bars represent mean ± standard error of the
mean (SEM).
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The western blot revealed that IRS-2 protein levels were
decreased in the livers of AdKO mice (Figure 1A), and IRS-2
phosphorylation by insulin was reduced (Figure 1B), while
IRS-1 protein expression and its phosphorylation by insulin
were relatively unaltered. Adiponectin administration in AdKO
mice upregulated IRS-2 phosphorylation associated with its
protein upregulation in liver (Figure 1C). These results prompted
us to examine the possibility that adiponectin regulated IRS-2
expression in liver.
Adiponectin Upregulated IRS-2 and Restored Insulin
Action in Livers of db/db Mice
We then administered adiponectin to db/db mice, an obese
animal model with insulin resistance and selective downregu-
lation of IRS-2 in the liver (Shimomura et al., 2000). Adiponec-
tin administration, which raised the plasma concentration of
adiponectin twice as high as preadministration levels (Fig-
ure S1A available online), restored hepatic IRS-2 protein and
its phosphorylation (Figure 2A). This led to the recruitment of
an adaptor molecule, the regulatory p85 subunit of phosphoi-
nositide-3 (PI3) kinase, as assessed by the coimmunoprecipi-
tation of IRS-2 and p85. In contrast, the expression and phos-
phorylation of insulin receptor (IR) and IRS-1 were unaltered
with adiponectin administration (Figure 2A). Insulin stimulation
after 4 hr of pretreatment with adiponectin showed partial
but significant restoration of the impaired insulin signaling
in livers of db/db mice, as evidenced by Akt and forkhead
transcription factor FoxO1 phosphorylation, accompanied by
IRS-2 upregulation (Figure 2B) and enhanced PI3 kinase
activity associated with IRS-2 (Figure 2C), while IRS-1 phos-
phorylation and the PI-3 kinase activity associated with IRS-
1 were unaltered. We also confirmed that adiponectin restored
the downregulated IRS-2 and led to enhanced insulin signaling
in high fat diet-induced obese mice (Figures S1B and S1C).
These results indicated that adiponectin restored the attenu-402 Cell Metabolism 13, 401–412, April 6, 2011 ª2011 Elsevier Inc.ated insulin actions in liver of obese model mice via IRS-2
upregulation.
Time course experiments showed that adiponectin robustly
upregulated hepatic Irs2 messenger RNA (mRNA) at 2 hr (Fig-
ure 2D) and transiently and maximally increased IRS-2 protein
at 4 hr (data nor shown). Importantly, adiponectin administration
to db/db mice did not alter plasma glucose and insulin levels
during 0.5–2 hr (data not shown), indicating that the changes in
IRS-2 expression were the primary effects of adiponectin but
not the consequence of altered plasma glucose or insulin levels,
which could secondarily modulate IRS-2 expression. Moreover,
adiponectin administration also increased IRS-2 protein in the
livers of wild-type mice (Figure S1D).
The enhanced insulin signaling by adiponectin in the livers of
db/dbmicewas associated with suppressedmRNA expressions
of key gluconeogenic enzymes, phosphoenolpyruvate carboxy-
kinase (Pck1) and glucose-6-phosphatase (G6pc) (Figure S1E)
and led to lower plasma glucose concentrations in a pyruvate
tolerance test (Figure S1F), suggesting that adiponectin adminis-
tration suppressed gluconeogenesis in liver. In addition, adipo-
nectin decreased the mRNA expression of sterol regulatory
element binding protein 1c (Srebf1). Hepatic de novo lipogen-
esis, as assessed by 3H and 14C incorporation into saponified
triglyceride, also tended to be lower in adiponectin-treated
db/db mice (Figure S1G and Figure S1H).
Adiponectin Activated STAT3 in Liver, which Was
Associated with Elevated Plasma IL-6 Concentration
Previously, we identified AdipoR1 and R2 as the receptors for
adiponectin, both of which are abundant in the liver (Yamauchi
et al., 2003), while T-cadherin, another possible receptor for adi-
ponectin, is abundant in the cardiovascular system (Hug et al.,
2004). We therefore hypothesized that adiponectin regulated
IRS-2 expression directly through AdipoR1 or R2 in the liver.
However, knockdown of neither AdipoR1 nor R2 in the liver
attenuated Irs2 upregulation by adiponectin (Figures S2A and
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Figure 2. Adiponectin Upregulated IRS-2 Expression in the Liver of db/db Mice
(A–C) The representative blots of insulin signaling in the liver of db/db mice administered with adiponectin.
(A) db/db mice and their control misty/misty mice were injected with adiponectin (Ad) at the fasted state, and the livers were removed at 4 hr. The lysates were
immunoprecipitated with insulin receptor (IR), IRS-1, and IRS-2 antibody, respectively, and were subjected to immunoblotting with 4G10 anti-phosphotyrosine
(pY), IRS-1, IRS-2, and p85 subunit of PI3Kinase (p85) antibody.
(B) db/dbmice and their controlmisty/mistymice were administered with Ad at the fasted state, and after 4 hr the mice were injected with insulin (Ins) via inferior
venae cavae. The livers were removed at 5 min, except for phospho-FoxO1 blotting, for which the livers were removed at 2 min. The lysates were immunopre-
cipitated with IR, IRS-1, and IRS-2 antibody, respectively, and were subjected to immunoblotting with pY, IRS-1, IRS-2, p85, pAkt, and pFoxO1 antibody. The
arbitrary quantifications are shown in the right-hand panels (n = 6, *; p < 0.05).
(C) db/dbmice and their controlmisty/mistymice were injected with Ad at the fasted state, and after 4 hr the mice were injected with insulin (Ins) via inferior venae
cavae. The livers were removed at 2 min and subjected to PI3 kinase assay as described in the Experimental Procedures.
(D) RT-PCR analysis of Irs2 mRNA in the liver of db/db mice at indicated hours after Ad administration (n = 4, * p < 0.05).
Error bars represent mean ± SEM. See also Figure S1.
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Irs2 in cultured hepatocytes (Figure S2C). These data raised
the possibility that adiponectin indirectly upregulated hepatic
IRS-2 through a previously unknown pathway.
To determine the mechanism of IRS-2 upregulation by adipo-
nectin, we examined the changes in various signaling molecules
in the liver after adiponectin administration, including those that
had not been reported to regulate IRS-2. Of these, we noted
strong phosphorylation of STAT3 in liver (Figure 3A). The time
course in which the expression of the suppressor of cytokine
signaling-3 (Socs3), the well-known downstream molecule of
STAT3, was upregulated was almost identical with the time
course in which Irs2 was upregulated (Figure 3B), suggesting
that Irs2 and Socs3 were upregulated by common upstream
signaling(s). As expected, adiponectin stimulation of Fao cellsCdid not cause STAT3 phosphorylation (Figure 3C). From these
data, we had an assumption that adiponectin induced some bio-
logical substances in the plasma, which then induced hepatic
STAT3 phosphorylation and IRS-2 expression secondarily,
although it had not been reported that STAT3 directly regulated
IRS-2 expression.
Surprisingly indeed, we found that adiponectin administration
caused an acute and transient increase of plasma IL-6, a potent
activator of STAT3 (Figure 3D), the time course of which
was coincident with the STAT3 phosphorylation in liver. Il6
mRNA was strongly upregulated in white adipose tissue (WAT)
after adiponectin administration, while the Il6 mRNA in liver
was also upregulated to a much lesser extent (Figure 3E, left
panel). Further analysis revealed that Il6 induction was more
prominent in visceral WAT than in subcutaneous WAT, with theell Metabolism 13, 401–412, April 6, 2011 ª2011 Elsevier Inc. 403
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Figure 3. Hepatic STAT3 activation and IL-6 Induction after Adiponectin Administration
(A and B) The representative blot of pSTAT3/STAT3 (A) and RT-PCR analysis of Socs3mRNA (B) in the liver of db/dbmice after adiponectin administration. db/db
mice were injected with adiponectin (Ad) at the fasted state, and the livers were removed at the indicated hours. The lysates were immunoprecipitated with anti-
STAT3 antibody and subjected to immunoblotting with pSTAT3 or STAT3 antibody. The total mRNA extracted from the livers was subjected to RT-PCR analysis
(n = 7-12, * p < 0.05).
(C) The representative blots of pSTAT3/ STAT3 and pAMPK/AMPK in Fao cells stimulated with Ad. Fao cells were stimulated with Ad at indicated time, and
the lysates were immunoprecipitated with anti-STAT3 antibody and subjected to immunoblotting with pSTAT3 or STAT3 antibody. The total cell lysates were
subjected to western blotting with pAMPK and AMPK antibody.
(D) The plasma IL-6 concentration after adiponectin administration. db/dbmice were injected with Ad at the fasted state. The plasma collected at indicated hours
was subjected to ELISA assay (n = 7-12, * p < 0.05).
(E) RT-PCR analysis of Il6mRNA in liver and variousWAT depots. db/dbmicewere injectedwith Ad at the fasted state, and the livers and the adipose tissueswere
removed at 2 hr. The total mRNA was extracted and subjected to RT-PCR analysis (n = 5-7, * p < 0.05).
(F) The representative blot of the diurnal changes in plasma adiponectin concentrations and their arbitrary quantification. The blood samples of db/db and their
control misty/misty mice collected at the fasted or refed state were subjected to immunoblotting with anti-adiponectin antibody (n = 4, * p < 0.05).
(G) The diurnal changes of Il6mRNA expression in perigonadal WAT. db/db and their controlmisty/mistymice were sacrificed at the fasted and refed state. The
total mRNA was extracted from the perigonadal WAT and subjected to RT-PCR analysis (n = 4-5, * p < 0.05).
Error bars represent mean ± SEM. See also Figure S2.
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panel).
These data prompted us to hypothesize that adiponectin
induced IL-6, which then activated hepatic STAT3 and subse-
quently upregulated IRS-2. Importantly, IRS-2 expression phys-
iologically increases during fasting, and its function is crucial in
the fasted state (Kubota et al., 2008). Indeed, consistent with
our hypothesis, Il6 expression was upregulated in the fasted
state in WAT of wild-type mice and was associated with
increased plasma adiponectin levels (Figures 3F and 3G). In
contrast, Il6 expression was highly and persistently upregulated
in db/dbmice with continuous downregulation of plasma adipo-
nectin levels, regardless of the feeding state (Figures 3F and 3G).404 Cell Metabolism 13, 401–412, April 6, 2011 ª2011 Elsevier Inc.IRS-2 Upregulation by Adiponectin was Mediated
by Hepatic STAT3 Activation via IL-6
To verify our hypothesis, we first abrogated IL-6 action either
by using neutralizing antibody or through genetic ablation (IL-6
knockout [KO] mice). Antibody-mediated IL-6 neutralization
significantly attenuated hepatic STAT3 phosphorylation by
adiponectin and abrogated the adiponectin-induced Irs2 upre-
gulation despite robust Il6 induction (Figure 4A), which was
confirmed by mRNA expression in perigonadal WAT. Moreover,
in IL-6 KO mice, adiponectin-induced STAT3 phosphorylation
and Irs2 upregulation were totally abolished (Figure 4B).
In contrast, IL-6 administration upregulated Irs2 mRNA and
its phosphorylation in liver (Figure 4C) after phosphorylation of
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Figure 4. IL-6/STAT3 Signaling and Hepatic IRS-2 Upregulation by Adiponectin
(A) STAT3 signaling and IRS-2 induction with anti-IL6 antibody pretreatment. C57BL/6J mice pretreated with anti-IL6 antibody as described in the Experimental
Procedures were injected with adiponectin (Ad) intraperitoneally, and the livers and perigonadal WAT were removed at 2 hr. The lysates of the livers were sub-
jected to immunoblotting with pSTAT3/STAT3 antibody. The total mRNA was subjected to RT-PCR analysis for Irs2 expression in liver and Il6 expression in peri-
gonadal WAT (n = 5, * p < 0.05).
(B) STAT3 signaling and IRS-2 induction in IL-6 KO mice. IL-6KO mice and their control C57BL/6J (wild) mice were injected with Ad intraperitoneally, and the
livers were removed at 2 hr. The lysates of the livers were subjected to immunoblotting with pSTAT3/STAT3 antibody. The total mRNA was subjected to
RT-PCR analysis for Irs2 expression in liver (n = 5, * p < 0.05).
(C) STAT3 signaling and IRS-2 expression in liver after IL-6 administration. C57BL/6Jmice were injected with recombinant human IL-6 intraperitoneally. The livers
were removed at the indicated hours. The total mRNA extracted from the liver at 1 hr after IL-6 administration was subjected to RT-PCR analysis. The lysates of
each liver sample were subjected to immunoprecipitation with the antibody for IRS-2, gp130, and STAT3, respectively, and subjected to immunoblotting with
4G10 anti-phosphotyrosine (for pIRS-2 and pgp130), gp130, pSTAT3, and STAT3 antibody as indicated (n = 5-6, * p < 0.05).
(D) STAT3 signaling and IRS-2 induction in LST3KO. LST3KO or their control flox/flox mice (floxed) were injected with Ad intraperitoneally, and the livers and
perigonadal WATwere removed at 2 hr. The lysates of the livers were subjected to immunoblotting with pSTAT3/STAT3 antibody. The total mRNAwas subjected
to RT-PCR analysis for Irs2 expression in liver and Il6 expression in perigonadal WAT (n = 4-6, * p < 0.05).
Error bars represent mean ± SEM.
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after IL-6 administration occurred at 0.5–1 hr (data not shown),
whereas the maximal STAT3 phosphorylation and Irs2 upregula-
tion after adiponectin administration occurred at 2 hr, further
supporting that adiponectin secondarily upregulated IRS-2 via
IL-6 induction.
Next, we administered adiponectin to mice with targeted
disruption of STAT3 specifically in hepatocytes (LST3KO). In
the livers of LST3KO mice, adiponectin-induced STAT3 phos-
phorylation and Irs2 upregulation were totally abolished, while
Il6 induction by adiponectin was similar to that seen in the control
flox/flox mice (Figure 4D). Collectively, these data indicated that
adiponectin upregulated IRS-2 through STAT3 activation in
hepatocytes in an IL-6-dependent manner.CAdiponectin-Induced IRS-2 Upregulation Was Mediated
by STAT3 Recruitment to Irs2 Promoter in Hepatocytes
Next, we focused on IRS-2 regulation by STAT3. Adenoviral-
mediated overexpression of a constitutively active form of
STAT3 (CA-STAT3) significantly increased IRS-2 in Fao cells
(Figure 5A). Luciferase assay showed that wild-type (WT) or
CA-STAT3 overexpression robustly enhanced Irs2 promoter
activity of the 1300 bps region, while the induction was
diminished in the promoter deleted up to 500 bps (Figure 5B).
The promoter region from 500 to 1300 bps contains multiple
potential STAT3 binding sites. Indeed, chromatin immunopre-
cipitation (ChIP) assay in vivo confirmed that immunoprecipita-
tion with STAT3 antibody significantly enriched the Irs2 promoter
regions in the livers at 1 and 2 hr after adiponectin administration,ell Metabolism 13, 401–412, April 6, 2011 ª2011 Elsevier Inc. 405
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Figure 5. STAT3 Involvement in Hepatic IRS-2 Upregulation by Adiponectin
(A) Fao cells were infected with adenovirus encoding constitutively active STAT3 (CA) or LacZ. At 48 hr after infection, the cells were subjected to immunopre-
cipitation and immunoblotting with STAT3 and IRS-2 antibody, respectively. The total mRNA was subjected to RT-PCR analysis (n = 4, * p < 0.05).
(B) Irs2 promoter activity in Fao cells. Fao cells transfected with the reporter vector harboring1300 or500 bp Irs2 promoter were overexpressed with wild-type
(WT) or CA STAT3. The cells were subjected to luciferase assay. The arbitrary units of luciferase activity are shown (n = 4, * p < 0.05).
(C) Chromatin immunoprecipitation of Irs2 promoter regions with STAT3 antibody in liver. db/dbmice were injected with adiponectin (Ad) at the fasted state, and
the livers were removed at the indicated hours. The western blot of pSTAT3 and the mRNA expression of Irs2 are shown in the left panels. The livers were immu-
noprecipitated with anti-STAT3 antibody, and3000 to3400,2000 to2500, and550 to850 of Irs2 promoter region in the immunoprecipitated DNA was
quantified by RT-PCR analysis. Fold enrichment compared to immunoprecipitation with control IgG antibody is shown (n = 3, * p < 0.05).
Error bars represent mean ± SEM.
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(Figure 5C).
Adiponectin Induced IL-6 from Macrophages
We next investigated the origin of IL-6 induction by adiponectin.
Fractionation experiments of the perigonadal WAT of adiponec-
tin-treated db/db mice revealed that Il6 mRNA was almost
exclusively detected in the stromal vascular cell (SVC) fraction
(Figure 6A). This finding was consistent with the immunohisto-
chemistry analyses showing that IL-6 was exclusively costained
with F4/80 in perigonadal WAT of adiponectin-treated db/db
mice (Figure 6B). Indeed, adiponectin strongly upregulated Il6
expression in cultured macrophages such as RAW264.7 cells
or primary peritoneal macrophages, and not in fully differentiated
3T3L1 adipocytes (Figure 6C). We also conducted bone marrow
transplantation (BMT) experiments, in which IL-6 KO mice were
transplanted with BM from either IL-6 KOmice or wild-typemice.
At 8 weeks after BMT, >99% of the leukocytes in peripheral
blood were repopulated by donor cells (data not shown). IL-6406 Cell Metabolism 13, 401–412, April 6, 2011 ª2011 Elsevier Inc.KO mice with the wild-type BM showed robust IL-6 induction
by adiponectin and displayed significant Irs2 upregulation in liver
(Figure 6D), indicating that the IL-6 from BM-derived mononu-
clear cells was sufficient for IRS-2 induction by adiponectin.
Importantly, adiponectin stimulation did not induce Il6 in Fao
cells (data not shown), indicating that the weak Il6 mRNA
induction observed in the livers of db/db mice or IL-6 KO mice
transplanted with wild-type BM could be accounted for by non-
hepatocyte cells, such as Kupffer cells or the resident macro-
phages in liver.
Adiponectin Induced IL-6 via NFkB Pathway
in a Form-Dependent Manner, Independently
of AdipoR1/AdipoR2
We further investigated the mechanism of IL-6 induction by adi-
ponectin. Adiponectin-induced IL-6 production was associated
with a decrease of IkBa, the inhibitory molecule of NFkB, in peri-
gonadal WAT (Figure 7A). Indeed, ChIP assay with mouse perito-
neal macrophages showed that immunoprecipitation with NFkB
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Figure 6. Upregulation of IL-6 by Adiponectin from Macrophages
(A) Il6 expression in stromal vascular cells (SVCs) and adipocytes from perigonadal WAT of db/dbmice injected with adiponectin. The db/dbmice were injected
with adiponectin (Ad) at the fasted state, and the perigonadal WAT was removed at 2 hr. SVCs and adipocytes were fractionated and subjected to mRNA extrac-
tion and RT-PCR analysis.
(B) IL-6 staining of perigonadal WAT after adiponectin administration. db/db mice were injected with Ad at the fasted state, and the perigonadal WAT was
removed at 2 hr. The samples were subjected to immunostaining for F4/80 (red), IL-6 (green), and DNA (blue).
(C) RT-PCR analysis for Il6mRNA expression in RAW264.7 cells, primary peritoneal macrophages and fully differentiated 3T3L1 adipocytes after Ad stimulation
(n = 5, * p < 0.05).
(D) IL-6 induction and IRS-2 upregulation in IL-6 KOmice transplantedwith bonemarrow fromwild-type C57BL/6Jmice. The IL-6 KOmice transplantedwith bone
marrow fromwild-type C57BL/6Jmice (wt/KO) or IL-6 KOmice (KO/KO) were injected with Ad at the fasted state. The plasmawas collected, and the liver and
the perigonadal adipose tissues were removed at 2 hr. Plasma IL-6 concentration was determined by ELISA assay, and the total mRNA from the tissues was
subjected to RT-PCR analysis (n = 5–6, * p < 0.05).
Error bars represent mean ± SEM.
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of Il6 promoter region (Libermann and Baltimore, 1990) after
adiponectin stimulation (Figure 7B), suggesting that adiponectin
induced IL-6 in macrophages through transcriptional regulation
by NFkB.
Adiponectin exists in various forms in plasma such as trimer,
hexamer, and high molecular weight (HMW), as well as a proteo-
lytically cleaved form, globular adiponectin (Fruebis et al., 2001;
Waki et al., 2005). It has been reported that the globular, trimer,
and higher-molecular-weight forms of adiponectin activate
AMPK via AdipoR1, whereas the HMW form also activates
NFkB (Tsao et al., 2003). As nonreduced PAGE showed that
the full-length adiponectin that we prepared contained trimer,
hexamer, and higher-molecular-weight complexes (data not
shown), it was unclear which form of adiponectin was respon-Csible for IL-6 production in our study. In addition, adiponectin,
which we prepared from E. coli, was inevitably contaminated
with lipopolysaccharide (LPS), a strong inducer of IL-6 produc-
tion, although the degree of LPS was as low as 1 pg/mg
adiponectin after meticulous decontamination (data not shown).
To address these issues, we stimulated RAW264.7 cells with
various forms of adiponectin prepared from mammalian cells
or E. coli. The results showed that the full-length adiponectin
was the most potent, and the trimeric form was a less potent
inducer of IL-6, whereas globular adiponectin did not induce
IL-6 at all (Figure 7C). The form dependency was irrelevant to
whether adiponectin was prepared from mammalian cells or
E. coli.
Even more intriguingly, disruption of AdipoR1 and AdipoR2
(DKO) (Yamauchi et al., 2007) still showed robust upregulationell Metabolism 13, 401–412, April 6, 2011 ª2011 Elsevier Inc. 407
A B E
C
D
Figure 7. Upregulation of IL-6 via NFkB Pathway by Adiponectin in a Form-Dependent Manner Independently of Adiponectin Receptors
(A and B) Activation of NFkB pathway by adiponectin.
(A) The db/dbmice were injected with adiponectin (Ad) at the fasted state, and the perigonadal WAT was removed at 2 hr. The total cell lysates were subjected to
western blotting with the antibody for IkBa or b-actin.
(B) Chromatin immunoprecipitation of Il6 promoter with the antibody for p65 subunit of NFkB. The mouse primary peritoneal macrophages were stimulated with
Ad for 2 hr. The cells were immunoprecipitated with p65 antibody, and the precipitated DNA of NFkB binding site of Il6 promoter was quantified by RT-PCR anal-
ysis. The 5000 region of the Il6 promoter was used as the negative control. Fold enrichment compared to immunoprecipitation with control IgG antibody is
shown (n = 3, *; p < 0.05).
(C) RT-PCR analysis of Il6mRNA in RAW264.7 cells stimulatedwith various forms of adiponectin (Ad). RAW264.7 cells were stimulated with 25 mg/ml trimeric form
(Trimer), full-length (Full), or globular form (Glb) adiponectin prepared from HEK293 or E. coli for 2 hr. The total mRNA was subjected to RT-PCR analysis. (n = 4, *
p < 0.05).
(D and E) IL-6 induction and IkBa degradation in perigonadal adipose tissues of AdipoR KO mice. The mice with targeted disruption of AdipoR1 and AdipoR2
(DKO) or their control mice were injected with Ad at the fasted state. The perigonadal WAT was removed at 2 hr and the total mRNA was subjected to
RT-PCR analysis for Adipor1, Adipor2 and Il6 expression (n = 5, * p < 0.05; N.D., not detected) (D) or the total cell lysates were immunoblotted with IkBa, pAMPK
and b-actin antibody (E). The arbitrary quantifications of immunoblots were shown in the lower panel (n = 3–5, * p < 0.05).
Error bars represent mean ± SEM. See also Figure S3.
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degradation of IkBa by adiponectin was also observed, while
AMPK activation, the downstream molecule of AdipoR1, was
abrogated (Figure 7E). As T-cadherin (Cdh13) mRNA was unde-
tectable in RAW264.7 cells (data not shown), consistent with the
previous report (Ivanov et al., 2001), these data suggest that
there still exists an unidentified molecule in macrophages func-
tioning as the receptor for hexamer or HMW adiponectin that
mediates IL-6 upregulation.
DISCUSSION
In this study, we have discovered a pathway in which adiponec-
tin upregulates IRS-2 in liver. The data also suggest the exis-408 Cell Metabolism 13, 401–412, April 6, 2011 ª2011 Elsevier Inc.tence of an unidentified adiponectin receptor and indicate that
the activation of STAT3 and subsequent increase in IRS-2 are
mediated by IL-6 (Figure S3).
As previously reported, adiponectin activates AMPK, which
suppresses gluconeogenic gene expressions (Yamauchi et al.,
2002). Here, we propose that the IRS-2-mediated insulin-sensi-
tization could be, besides AMPK activation, another mechanism
whereby adiponectin exerts its antidiabetic actions. IRS-2
upregulation by adiponectin suppresses gluconeogenesis but
does not enhance lipogenesis, consistent with our previous
report showing that the suppression of SREBP1c is mediated
largely via AMPK (Awazawa et al., 2009) and that IRS-2 mainly
contributes to suppression of gluconeogenesis by insulin
(Kubota et al., 2008).
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functions in liver. Especially during the fasted state, IRS-2
increases and plays pivotal roles at its peak level immediately
after refeeding (Kubota et al., 2008), while IRS-1 dominates
during refeeding or in refed conditions (Guo et al., 2009). To
date, several pathways have been identified to regulate IRS-2
expression, such as cAMP response element binding protein
(CREB) and FoxO1 during fasting (Ide et al., 2004; Jhala et al.,
2003; Shimomura et al., 2000) and SREBP1c after refeeding
(Ide et al., 2004). Our findings suggest a mechanism of IRS-2
regulation via STAT3.
IL-6 activates STAT3 via IL-6 receptor/gp130 complex, while
STAT3 is known to be phosphorylated by other cytokines (Levy
and Darnell, 2002). Previous reports have suggested that the
activation of gp130 interfacing with receptors other than the
IL-6 receptor also contributes to STAT3 activation by IL-6 (Ernst
et al., 2001). In our experiment, STAT3 phosphorylation reached
its peak at 0.5–1 hr after IL-6 administration, whereas plasma
IL-6 elevation and the maximal STAT3 phosphorylation concur-
rently occurred at 1–2 hr after adiponectin administration.
Comparing the time course of these suggests that STAT3 activa-
tion induced by adiponectin is via the direct binding of IL-6 to the
IL-6/gp130 receptor, although the possibility still remains that
other ligand-receptor interactions are also involved.
Although IL-6 has usually been related to insulin resistance
(Pradhan et al., 2001), some reports have paradoxically sug-
gested that IL-6 contributes to improved insulin sensitivity
(reviewed in Pedersen and Febbraio, 2008). Our data indicate
that transient elevation of IL-6 levels leads to IRS-2 upregulation
andenhances insulin signaling in liver. In contrast, in obesemodel
mice, hepatic IRS-2 is downregulated in liver in spite of chronic
plasma IL-6 elevation, possibly due to hyperinsulinemia. Even
under thesepathological conditions, the transient further increase
in IL-6 levels accomplished by therapeutic administration of adi-
ponectin leads to STAT3 phosphorylation and IRS-2 upregula-
tion, suggesting that the acute change in IL-6 level, regardless
of its absolute value, is critical for the subsequent STAT3 activa-
tion and IRS-2 upregulation. Indeed, transient IL-6 upregulation
occurs in some physiologic circumstances such as muscle
contraction, which is implicated in insulin sensitivity (Febbraio
et al., 2004; Kelly et al., 2009). We have also found that in physio-
logic conditions IL-6 and adiponectin show similar diurnal varia-
tion in their expressions with their peaks in the fasting state,
although the causal relations between these circadian changes
and their physiological implications are not fully tested and need
to be further validated. There is also still much debate as to
whether chronically elevated IL-6 levels could actually contribute
to systemic insulin resistance in obesity (Holmes et al., 2008; Tor-
isu et al., 2007); this concept awaits future research.
We have shown by in vitro and BMT experiments that the
macrophages mediate, and are sufficient for, the IL-6 induction
and the resultant IRS-2 upregulation by adiponectin. Whereas
IL-6 is known to be produced in adipocytes (Fain et al., 2004;
Kershaw and Flier, 2004), our results consistently indicate that
the IL-6 is mainly derived from SVCs, although the experiment
using isolated SVCs could have a limitation due to the strong
induction of IL-6 during the isolation process (Ruan et al.,
2003). However, our data indicate that the Il6 induction in liver
by adiponectin originated in non-hepatocyte cells such asCKupffer cells, consistent with our previous report showing that
AdipoR1/2 are the only functional receptors in hepatocytes
(Yamauchi et al., 2007).We hypothesize that the unknown adipo-
nectin receptor suggested here, which mediates Il6 induction via
the NFkB pathway, is expressed in macrophages but not in
hepatocytes or adipocytes. This hypothesis explains the strong
and specific IL-6 production in macrophages induced by adipo-
nectin, although we could not completely rule out the possibility
that other cells or tissues also contribute to IL-6 induction by
adiponectin. The identification of the still unknown receptor in
the future will resolve this issue and will also add depth to our
knowledge about the field of metabolism by clarifying the signifi-
cance of IRS-2 regulation as well as IL-6 induction by adiponec-
tin in physiological or pathophysiological settings.
Previous reports indicate that adiponectin suppresses inflam-
matory responses induced by hyperglycemia (Devaraj et al.,
2008) or TNF-a (Zhang et al., 2009), while others have reported
that adiponectin by itself activates NFkB and promotes inflam-
matory cytokine production (Haugen and Drevon, 2007; Rovin
and Song, 2006). The important aspect of this issue is that
adiponectin could exert diverse effects upon inflammation and
metabolism through different pathways. AMPK, as an anti-
inflammatory molecule, is activated by various forms of adipo-
nectin (Tsao et al., 2002), presumably via AipoR1, while NFkB
has been shown to be activated by the HMW form (Tsao et al.,
2003). As we have shown here, IL-6 is upregulated by adiponec-
tin, whereas AMPK activation is totally abolished, in AdipoR1
and R2 knockout mice. T-cadherin, another possible receptor
for hexameric and HMW forms of adiponectin in the cardiovas-
cular system (Denzel et al., 2010; Hug et al., 2004), is undetect-
able in macrophages in vivo (Ivanov et al., 2001) and in
RAW264.7 cells in our own study. These data indicate that there
still exists an unidentified molecule in macrophages functioning
as the receptor for hexamer or HMW adiponectin, and that adi-
ponectin could exert distinct actions through different receptors
in a context-dependent manner.
In conclusion, we have unraveled an insulin-sensitizing action
initiated by adiponectin leading to upregulation of hepatic IRS-2
via a macrophage-derived IL-6-dependent pathway. Our data
not only provide insight into adiponectin biology including the
existence of a still unidentified adiponectin receptor, but also
challenge the widely accepted idea about how IL-6/STAT3
signaling serves for systemic glucose metabolism, suggesting
the possibility that recovery or creation of diurnal variations of
adiponectin/IL-6 axis can be a therapeutic strategy for obesity-
induced insulin resistance.EXPERIMENTAL PROCEDURES
Reagents
Recombinant adiponectin was prepared as described previously (Yamauchi
et al., 2002). Trimeric and full-length forms of adiponectin derived from
HEK293 cells, and globular adiponectin derived from E. coli were purchased
fromProSpec.Globular adiponectin derived fromHEK293cellswaspurchased
from Alexis Biochemicals. Recombinant human IL-6 was purchased from R&D
systems.
Animals
BKS.Cg-m +/+ Leprdb/J (db/db) mice and C57BL/6J mice were purchased
from Japan CLEA. C57BL/6J.129S6-Il6tm1Kopf (IL-6 KO) mice were purchasedell Metabolism 13, 401–412, April 6, 2011 ª2011 Elsevier Inc. 409
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mice were described previously (Kubota et al., 2002; Yamauchi et al., 2007).
LST3KO mice were kindly provided by H. Inoue and M. Kasuga (Inoue et al.,
2004). The mice were injected with 3 mg/g BW recombinant adiponectin intra-
peritoneally after overnight fasting at the age between 8 and 10 weeks. A total
of 1 mg/g BW recombinant human IL-6 was injected to C57BL/6J mice (Cress-
man et al., 1996; Yamada et al., 1997). For western blotting, five units of insulin
was injected into the inferior venae cavae of anesthetized mice, and the livers
were removed after 5 min, except for western blotting of phospho-FoxO1,
where the livers were removed after 2 min. The Animal Care Committee of
the University of Tokyo approved the animal care and experimental
procedures.
Immunoprecipitation and Immunoblotting
Immunoprecipitation and immunoblotting were conducted as previously
described (Awazawa et al., 2009). The blood samples were collected from
the mice after 24 hr fasting or 4 hr refeeding, and 1 ml plasma was subjected
to adiponectin immunoblotting. 4G10, anti-IRS-1, anti-IRS-2, and anti-PI3-K
p85 subunit N-SH2 antibodies were purchased from Millipore. Anti-insulin
receptor antibody (C-19) and anti-gp130 antibody (C-20) were purchased
from SantaCruz Biotechnology. Antibody for the p65 subunit of NFkB
(ab7970) and adiponectin were purchased from Abcam. All the other anti-
bodies were purchased from Cell Signaling Technology.
PI3 Kinase Assay
Five units of insulin was injected into the inferior venae cavae of anesthetized
mice, and the livers were removed after 2 min. PI3 kinase activities in the
liver was determined in immunoprecipitates with the indicated antibodies
as previously described (Ueki et al., 2000). The phosphorylated lipids were
visualized by autoradiography with an image analyzer (BAS 2000; Fuji Film,
Tokyo).
Quantitative Real-Time PCR
The total RNA was prepared by RNeasy kit (QIAGEN). Complementary DNA
was preparedbyReverse TranscriptionReagents (AppliedBiosystems). Quan-
titative real-time PCR was performed with ABI Prism with PCR Master Mix
Reagent (Applied Biosystems) except for quantification of Il6 mRNA in BMT
experiment, where Power SYBR Green PCR Master Mix was used with the
primers as follows: fwd, TTCCATCCAGTTGCCTTCTTGG; rev, TTCTCATTTC
CACGATTTCCCAG. Levels of mRNA were normalized to that of cyclophilin
(Awazawa et al., 2009). The other primers and probes were purchased from
Applied Biosystems.
Cells and Cell Culture
RAW264.7 cells and fully differentiated 3T3L1 cells were cultured in DMEM
(GIBCO) medium. Fao cells were cultured in RPMI1640 (GIBCO) medium.
Primary peritoneal macrophages were isolated from 8-week-old male
C57BL/6J mice injected with 3% thioglycollate. Isolation of adipocytes and
SVCs was conducted as previously described (Kamei et al., 2006). All the
media were supplemented with 10% (vol/vol) fetal bovine serum (GIBCO).
Where indicated, the cells were infected with adenoviruses and harvested
48 hr after infection, and cells were stimulated with 25 mg/ml adiponectin.
Generation and Infection of Adenoviruses
Adenovirus of a constitutively active form of STAT3 was kindly provided by
H. Inoue and M. Kasuga (Kobe University) (Inoue et al., 2004). Prior to use,
all adenoviruses were purified on a cesium chloride gradient and dialyzed
into PBS plus 10% glycerol. The cells were infected with the adenoviruses
at the MOI (multiplicity of infection, or number of viral particles per cell) of
1000 PFU/cell.
IL-6 Neutralization
C57BL/6J mice were injected with 47 mg of anti-IL6 antibody or its isotype
control (R&D Systems) via tail vein. The following day after overnight fasting,
the mice were injected with 3 mg/g BW recombinant adiponectin intraperitone-
ally and sacrificed at 2 hr.410 Cell Metabolism 13, 401–412, April 6, 2011 ª2011 Elsevier Inc.Luciferase Assay
Luciferase reporter plasmid harboring 50-flanking region of mouse Irs2 exon 1
was subcloned to pGL3 basic vector. Fao cells plated onto a 24-well plate
were transfected with 0.5 mg of each luciferase reporter plasmid and 0.02 mg
Renilla luciferase plasmid with HSV-TK promoter (phRL-TK, Promega) with
Lipofectamine 2000 (Invitrogen). On the fourth day, the cells were harvested
and the luciferase activity was measured by Dual-Luciferase Reporter Assay
System (Promega) according to the manufacture’s protocol.
Chromatin Immunoprecipitation Assay
ChIP assay was conducted as previously described (Friedman et al., 2004).
In brief, mouse peritoneal macrophages or 1 g mouse liver was crosslinked
in 1% formaldehyde/PBS. The tissue was suspended in lysis buffer (50 mM
Tris-HCl [pH 8.1], 10 mMEDTA, 1%SDS, and protease inhibitor) and the chro-
matin was sheared by Bronson Sonifier 250D. The lysates were diluted five
times with dilution buffer (16.7 mM Tris-HCl [pH 8.1], 167 mM NaCl, 1.2 mM
EDTA, 0.01% SDS, 1.1% Triton X-100, and protease inhibitor). The chromatin
solution was incubated with 2 mg primary antibodies and Dynabeads Protein A
(Invitrogen). The beads were rinsed with wash buffer (50 mM HEPES-KOH
[pH 7.0], 0.5 M LiCl, 1 mM EDTA, 0.7% sodium deoxycholate, and 1%
NP-40) and immune complexes were eluted from beads with elution buffer
(50 mM Tris-HCl [pH 8.0], 10 mM EDTA, 1% SDS) at 65 C. Eluates were addi-
tionally incubated at 65C to reverse crosslinking and then incubated with
0.5 mg/ml Proteinase K at 55 C. DNA was purified with MinElute PCR purifi-
cation kit (QIAGEN). The immunoprecipitated DNA regions were quantified by
real time PCR using ABI Prism. (See also Table S1.)
Immunohistochemistry
The perigonadal fat pads were fixed in 4% paraformaldehyde in PBS and
embedded in paraffin. The sections were incubated with rat F4/80 antibody
(Serotec) (1:250 dilution) and goat IL-6 antibody (Santa Cruz) (1:50 dilution)
at 4C, followed by incubation with anti-rat IgG RITC (Santa Cruz) and anti-
goat IgG FITC (Santa Cruz) for 1 hr at room temperature. Hoechst staining
(1:400 dilution) was performed for 20 min at room temperature. The sections
were mounted with Fluorescent Mounting Medium (DAKO) and examined
under a fluorescence microscope (BZ-8000) (KEYENCE).
Analytical Procedures
Blood samples were collected by tail bleed. Plasma adiponectin and IL-6
concentrations were quantified by ELISA assay (Ohtuka Pharmaceuticals
and R&D Systems, respectively).
Bone Marrow Transplantation
Bone marrow cells were collected by flushing of the femurs and tibiae of the
mice at 6 weeks of age. The nucleated cells were counted and injected intra-
venously into lethally irradiated (10 Gy) male IL-6 KO mice at 6 weeks of age.
The mice were maintained under normal chow diet for 8 weeks before exper-
iments. For chimerism assay, the genomic DNA purified from the blood
samples was subjected to Real-time PCR as previously described (Ichikawa
et al., 2008).
Statistical Analysis
Statistical analysis was performed by two-sample t test assuming unequal
variances or paired two-sample t test for means. Statistical significance was
accepted at p < 0.05 unless otherwise indicated.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
doi:10.1016/j.cmet.2011.02.010.
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